Search
for
Sort by
Research 121–150 of 326
- Microneedles mediated bioinspired lipid nanocarriers for targeted treatment of alopecia
- Post-finasteride syndrome: An emerging clinical problem
- 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction
- Towards a consensus on how to diagnose and quantify female pattern hair loss – The ‘Female Pattern Hair Loss Severity Index (FPHL-SI)’
- Inhibitory activities of some traditional Chinese herbs against testosterone 5α-reductase and effects of Cacumen platycladi on hair re-growth in testosterone-treated mice
- Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases
- Herbal Extracts Induce Dermal Papilla Cell Proliferation of Human Hair Follicles
- Pre-clinical non-viral vectors exploited for<i>in vivo</i>CRISPR/Cas9 gene editing: an overview
- Androgenetic alopecia; drug safety and therapeutic strategies
- 5α-reductase activity in women with polycystic ovary syndrome: a systematic review and meta-analysis
- The endocrinology of baldness
- Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites
- Genetic basis of polycystic ovary syndrome
- Phytochemistry and pharmacological studies of Plumbago zeylanica L.: a medicinal plant review
- Candidate SNP markers of reproductive potential are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters
- Congenital adrenal hyperplasia
- Hormonal regulation in male androgenetic alopecia—Sex hormones and beyond: Evidence from recent genetic studies
- Steroid 5α-reductase 2 deficiency leads to reduced dominance-related and impulse-control behaviors
- Finasteride and androgenic alopecia; from therapeutic options to medical implications
- Morpho‐regulation in diverse chicken feather formation: Integrating branching modules and sex hormone‐dependent morpho‐regulatory modules
- Discovery of Natural Steroid 5 Alpha-Reductase Inhibitors
- Increased DHT levels in androgenic alopecia have been selected for to protect men from prostate cancer
- Big head? Bald head! Skull expansion: alternative model for the primary mechanism of AGA
- 11α-Hydroxyprogesterone, a potent 11β-hydroxysteroid dehydrogenase inhibitor, is metabolised by steroid-5α-reductase and cytochrome P450 17α-hydroxylase/17,20-lyase to produce C11α-derivatives of 21-deoxycortisol and 11-hydroxyandrostenedione in vitro
- Novel <i>ABCD1</i> Gene Mutation in Adrenomyeloneuropathy with Hypoplasia and Agenesis of the Corpus Callosum
- Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol
- DHT and E2 synthesis-related proteins and receptors expression in male yak skin during different hair follicle stages
- Intraethnic variation in steroid-5-alpha-reductase polymorphisms in prostate cancer patients: a potential factor implicated in 5-alpha-reductase inhibitor treatment
- The oestrogen receptor 2 (<i>ESR2</i>) gene in female-pattern hair loss: replication of association with rs10137185 in German patients